Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

2001680 citationsJournal Article

Authors

Good health and well-being

Published in: Breast Cancer Research and Treatment

Volume 65, Issue 2, pp. 125-134

Field-Weighted Citation Impact: 36.50